dr. pavlick on adjuvant immunotherapy in high-risk melanoma
Published 7 years ago • 262 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:14
dr. pavlick on importance of immunotherapy in metastatic melanoma
-
9:35
adjuvant treatment selection in high-risk melanoma
-
5:57
adjuvant ipilimumab in high-risk melanoma
-
0:59
dr. pavlick on the columbus trial in metastatic melanoma
-
1:54
dr. pavlick on immunotherapy clinical trials in basal and squamous cell carcinomas
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
5:54
adjuvant therapy in melanoma: safety and efficacy
-
6:04
using adjuvant therapy in patients with melanoma
-
9:18
adjuvant immunotherapy for melanoma
-
5:00
adjuvant therapy for stage iii melanoma
-
0:49
dr. weber on emerging therapies in melanoma
-
1:10
dr. christian blank on combining immunotherapy in high-risk melanoma
-
5:43
role of adjuvant radiation therapy in melanoma
-
1:30
adjuvant therapy for high-risk melanoma
-
7:17
neoadjuvant trials in high-risk melanoma
-
7:30
immunotherapy in advanced melanoma
-
1:43
adjuvant therapy in melanoma: what’s coming next?
-
0:43
keynote-716: adjuvant pembrolizumab for high-risk melanoma
-
7:03
adjuvant therapy for melanoma